| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| Gene symbol | COLEC10 | Synonyms | 3MC3, CL-10, CL-34, CLL1 | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.12 | dbXrefs | |
| Description | collectin subfamily member 10 | ||||
| GTO ID | GTC0981 |
| Trial ID | ChiCTR2200058044 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CLL1|CD33|CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD123/CD33/CLL1 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A single-arm, unblinded clinical study of safety and efficacy of autogenous CLL1/CD33/CD123 CAR T in patients with relapsed and refractory acute myeloid leukemia |
| Year | 2022 |
| Country | China |
| Company sponsor | Huizhou Municipal Central Hospital |
| Cohort 1 | |||||||||
|
|||||||||